Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$17.00
-1.2%
$15.00
$7.88
$17.43
$8.40B1.344.58 million shs3.69 million shs
Legend Biotech Co. stock logo
LEGN
Legend Biotech
$43.24
-5.0%
$54.67
$42.08
$77.32
$7.87B0.12998,017 shs887,585 shs
Envista Holdings Co. stock logo
NVST
Envista
$18.54
-3.8%
$20.49
$18.09
$36.14
$3.19B1.352.33 million shs2.69 million shs
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$27.89
-1.1%
$31.71
$26.27
$41.65
$5.79B13.43 million shs5.47 million shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
+1.93%+27.78%+12.82%+7.67%+91.17%
Legend Biotech Co. stock logo
LEGN
Legend Biotech
-0.44%-0.89%-19.23%-25.34%-35.20%
Envista Holdings Co. stock logo
NVST
Envista
+2.34%-2.68%-8.63%-12.12%-43.29%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
+1.40%-0.63%-14.16%-14.00%-31.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
3.1383 of 5 stars
1.35.00.00.33.13.31.3
Legend Biotech Co. stock logo
LEGN
Legend Biotech
2.4852 of 5 stars
4.50.00.00.02.61.70.6
Envista Holdings Co. stock logo
NVST
Envista
4.0504 of 5 stars
4.01.00.03.82.10.01.9
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
4.9295 of 5 stars
4.34.03.33.81.11.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.57
Moderate Buy$17.291.71% Upside
Legend Biotech Co. stock logo
LEGN
Legend Biotech
2.92
Moderate Buy$82.6491.13% Upside
Envista Holdings Co. stock logo
NVST
Envista
1.92
Reduce$25.8639.50% Upside
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
2.64
Moderate Buy$35.2226.29% Upside

Current Analyst Ratings

Latest XRAY, NVST, LEGN, and ELAN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2024
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$19.00 ➝ $23.00
5/9/2024
Legend Biotech Co. stock logo
LEGN
Legend Biotech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$87.00
5/6/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$34.00 ➝ $30.00
5/3/2024
Envista Holdings Co. stock logo
NVST
Envista
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$20.00 ➝ $17.50
5/3/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$40.00 ➝ $35.00
5/3/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$41.00 ➝ $38.00
5/3/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$35.00 ➝ $32.00
5/3/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$42.00 ➝ $36.00
5/3/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$35.00 ➝ $33.00
5/2/2024
Envista Holdings Co. stock logo
NVST
Envista
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$29.00 ➝ $23.00
5/2/2024
Envista Holdings Co. stock logo
NVST
Envista
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.37B1.92$2.89 per share5.88$12.63 per share1.35
Legend Biotech Co. stock logo
LEGN
Legend Biotech
$285.14M27.59N/AN/A$6.88 per share6.28
Envista Holdings Co. stock logo
NVST
Envista
$2.57B1.24$2.49 per share7.46$24.35 per share0.76
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$3.94B1.47$4.77 per share5.85$15.69 per share1.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$1.23B-$2.50N/A16.341.42-27.87%6.44%2.91%8/5/2024 (Estimated)
Legend Biotech Co. stock logo
LEGN
Legend Biotech
-$518.25M-$1.48N/A540.50N/A-181.75%-37.19%-25.34%5/13/2024 (Confirmed)
Envista Holdings Co. stock logo
NVST
Envista
-$100.20M-$0.72N/A13.0615.14-4.70%5.84%3.74%8/7/2024 (Estimated)
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
-$132M-$0.44N/A11.871.24-2.41%11.54%5.36%8/7/2024 (Estimated)

Latest XRAY, NVST, LEGN, and ELAN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2024N/A
Legend Biotech Co. stock logo
LEGN
Legend Biotech
-$0.23N/A+$0.23N/AN/AN/A  
5/8/2024Q1 2024
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.26$0.34+$0.08$0.62$1.18 billion$1.21 billion    
5/2/2024Q1 24
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.42$0.42N/A$0.75$969.45 million$953.00 million      
5/1/2024Q1 2024
Envista Holdings Co. stock logo
NVST
Envista
$0.31$0.26-$0.05$0.38$634.85 million$623.60 million    
3/11/2024Q4 2023
Legend Biotech Co. stock logo
LEGN
Legend Biotech
-$0.70-$0.40+$0.30-$0.40$95.63 million$76.50 million    
2/29/2024Q4 23
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.43$0.44+$0.01$0.56$972.61 million$1.01 billion    
2/26/202412/31/2023
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.10$0.08-$0.02$0.45$1.00 billion$1.04 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
Legend Biotech Co. stock logo
LEGN
Legend Biotech
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$0.642.29%+11.87%N/A 13 Years

Latest XRAY, NVST, LEGN, and ELAN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
quarterly$0.161.92%3/27/20243/29/20244/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.92
2.75
1.35
Legend Biotech Co. stock logo
LEGN
Legend Biotech
0.22
6.92
6.83
Envista Holdings Co. stock logo
NVST
Envista
0.34
2.27
1.93
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.54
1.43
0.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
Legend Biotech Co. stock logo
LEGN
Legend Biotech
70.89%
Envista Holdings Co. stock logo
NVST
Envista
N/A
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
95.70%

Insider Ownership

CompanyInsider Ownership
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.57%
Legend Biotech Co. stock logo
LEGN
Legend Biotech
0.02%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
0.52%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,300494.10 million491.28 millionOptionable
Legend Biotech Co. stock logo
LEGN
Legend Biotech
1,800181.91 million181.88 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,800171.86 million169.62 millionOptionable
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
15,000207.63 million206.55 millionOptionable

XRAY, NVST, LEGN, and ELAN Headlines

SourceHeadline
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAYDENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
businesswire.com - May 10 at 5:06 PM
Dentsply Sirona to Participate in Upcoming Investor ConferencesDentsply Sirona to Participate in Upcoming Investor Conferences
globenewswire.com - May 8 at 4:15 PM
DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $30.00DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $30.00
americanbankingnews.com - May 8 at 1:22 AM
Key Takeaways From Dentsply Sirona Analyst RatingsKey Takeaways From Dentsply Sirona Analyst Ratings
markets.businessinsider.com - May 6 at 7:20 PM
DENTSPLY SIRONA (NASDAQ:XRAY) Given New $30.00 Price Target at The Goldman Sachs GroupDENTSPLY SIRONA (NASDAQ:XRAY) Given New $30.00 Price Target at The Goldman Sachs Group
marketbeat.com - May 6 at 12:02 PM
Understanding Dentsply (XRAY) Reliance on International RevenueUnderstanding Dentsply (XRAY) Reliance on International Revenue
zacks.com - May 6 at 10:26 AM
Brokers Set Expectations for DENTSPLY SIRONA Inc.s Q1 2025 Earnings (NASDAQ:XRAY)Brokers Set Expectations for DENTSPLY SIRONA Inc.'s Q1 2025 Earnings (NASDAQ:XRAY)
americanbankingnews.com - May 6 at 3:34 AM
FY2024 Earnings Forecast for DENTSPLY SIRONA Inc. Issued By Leerink Partnrs (NASDAQ:XRAY)FY2024 Earnings Forecast for DENTSPLY SIRONA Inc. Issued By Leerink Partnrs (NASDAQ:XRAY)
americanbankingnews.com - May 6 at 2:42 AM
Earnings Miss: DENTSPLY SIRONA Inc. Missed EPS By 64% And Analysts Are Revising Their ForecastsEarnings Miss: DENTSPLY SIRONA Inc. Missed EPS By 64% And Analysts Are Revising Their Forecasts
finance.yahoo.com - May 5 at 4:34 PM
DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $38.00DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $38.00
americanbankingnews.com - May 5 at 6:18 AM
Needham & Company LLC Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $36.00Needham & Company LLC Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $36.00
americanbankingnews.com - May 5 at 6:18 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $35.00DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $35.00
americanbankingnews.com - May 5 at 6:18 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Rating Reiterated by Piper SandlerDENTSPLY SIRONA (NASDAQ:XRAY) Rating Reiterated by Piper Sandler
americanbankingnews.com - May 5 at 5:44 AM
DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $33.00DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $33.00
americanbankingnews.com - May 5 at 3:54 AM
StockNews.com Downgrades DENTSPLY SIRONA (NASDAQ:XRAY) to HoldStockNews.com Downgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold
americanbankingnews.com - May 5 at 3:54 AM
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of "Moderate Buy" from AnalystsDENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of "Moderate Buy" from Analysts
americanbankingnews.com - May 5 at 1:28 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by StockNews.comDENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by StockNews.com
marketbeat.com - May 4 at 12:28 AM
DENTSPLY SIRONA (NASDAQ:XRAY) Releases FY 2024 Earnings GuidanceDENTSPLY SIRONA (NASDAQ:XRAY) Releases FY 2024 Earnings Guidance
marketbeat.com - May 3 at 8:18 PM
DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $35.00 at Evercore ISIDENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $35.00 at Evercore ISI
marketbeat.com - May 3 at 8:08 PM
Dentsply Sirona Inc (XRAY) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...Dentsply Sirona Inc (XRAY) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
finance.yahoo.com - May 3 at 8:27 AM
Dentsply: Q1 Earnings SnapshotDentsply: Q1 Earnings Snapshot
timesunion.com - May 2 at 7:04 PM
Dentsply, Execs Must Face Investors’ Securities Fraud Class SuitDentsply, Execs Must Face Investors’ Securities Fraud Class Suit
news.bloomberglaw.com - May 2 at 7:04 PM
DENTSPLY SIRONA (NASDAQ:XRAY)  Shares Down 5.8% DENTSPLY SIRONA (NASDAQ:XRAY) Shares Down 5.8%
marketbeat.com - May 2 at 6:56 PM
DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/YDENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
zacks.com - May 2 at 2:06 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Elanco Animal Health logo

Elanco Animal Health

NYSE:ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Legend Biotech logo

Legend Biotech

NASDAQ:LEGN
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
Envista logo

Envista

NYSE:NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
DENTSPLY SIRONA logo

DENTSPLY SIRONA

NASDAQ:XRAY
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina